CompletedPhase 3NCT00283699
A Pilot Study of Neurocysticercosis Treatment
Studying Cysticercosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Columbia University
- Principal Investigator
- W. Allen Hauser, MDG.H. Sergievsky Center, Columbia University
- Intervention
- albendazole(drug)
- Enrollment
- 178 enrolled
- Eligibility
- All sexes
- Timeline
- 2001 – 2005
Study locations (5)
- Vicente Corral Moscoso Hospital of Cuenca, Centro de Epilepsia, Facultad de Ciencias Médicinas de la Universidad de Cuenca IDIUC (Área 5), Av. 12 de Abril. Cdla., Cuenca, Ecuador
- Teodoro Maldonado Carbo Hospital, Av. 25 de Julio Vía Puerto Marítimo, Guayaquil, Ecuador
- Baca Ortiz Children's Hospital, Av. Colon s/n y 6 de Diciembre, Quito, Ecuador
- Hospital Carlos Andrade Marin, Av. 10 de agosto y Bogotá, Quito, Ecuador
- Hospital Eugenio Espejo, Servicio de Neurología, Av. Colombia s/n, Quito, Ecuador
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00283699 on ClinicalTrials.govOther trials for Cysticercosis
Additional recruiting or active studies for the same condition.